ABIGAIL MOHRBACHER: Open Payments
NPI 1013214253 · PITTSBURGH, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$539 in 32 payments from 9 companies in 2025. Trend: 2023 $605 · 2024 $670 · 2025 $539
Food & beverage: $539
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 16 | $251 |
| GlaxoSmithKline, LLC. | 6 | $111 |
| Amgen Inc. | 3 | $55 |
| Lilly USA, LLC | 2 | $35 |
| Phathom Pharmaceuticals, Inc. | 1 | $21 |
| ABBVIE INC. | 1 | $18 |
| Exact Sciences Corporation | 1 | $18 |
| PFIZER INC. | 1 | $16 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $14 |
Products named: Ozempic, TRELEGY ELLIPTA, REPATHA, Wegovy, MOUNJARO, VOQUEZNA, AREXVY, QULIPTA.
Industry payments across PA — which companies pay providers there.
